These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30256919)

  • 1. Plasma Biomarkers to Detect Prevalent or Predict Progressive Tuberculosis Associated With Human Immunodeficiency Virus-1.
    Lesosky M; Rangaka MX; Pienaar C; Coussens AK; Goliath R; Mathee S; Mwansa-Kambafwile J; Maartens G; Wilkinson RJ; Wilkinson KA
    Clin Infect Dis; 2019 Jul; 69(2):295-305. PubMed ID: 30256919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects.
    Prabhavathi M; Ahamed Kabeer BS; Deenadayalan A; Raja A
    Tuberculosis (Edinb); 2016 Jan; 96():27-30. PubMed ID: 26786651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients.
    Khawcharoenporn T; Phetsuksiri B; Rudeeaneksin J; Srisungngam S; Apisarnthanarak A
    Jpn J Infect Dis; 2017 Sep; 70(5):502-506. PubMed ID: 28367883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Parsimonious Host Inflammatory Biomarker Signature Predicts Incident Tuberculosis and Mortality in Advanced Human Immunodeficiency Virus.
    Manabe YC; Andrade BB; Gupte N; Leong S; Kintali M; Matoga M; Riviere C; Samaneka W; Lama JR; Naidoo K; Zhao Y; Johnson WE; Ellner JJ; Hosseinipour MC; Bisson GP; Salgame P; Gupta A
    Clin Infect Dis; 2020 Dec; 71(10):2645-2654. PubMed ID: 31761933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
    Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
    J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.
    Vanini V; Petruccioli E; Gioia C; Cuzzi G; Orchi N; Rianda A; Alba L; Giancola ML; Conte A; Schininà V; Rizzi EB; Girardi E; Goletti D
    J Infect; 2012 Jul; 65(1):49-59. PubMed ID: 22465752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients.
    Nouhin J; Pean P; Madec Y; Chevalier MF; Didier C; Borand L; Blanc FX; Scott-Algara D; Laureillard D; Weiss L
    J Infect; 2017 May; 74(5):456-465. PubMed ID: 28189712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine and chemokine expression profiles in response to Mycobacterium tuberculosis stimulation are altered in HIV-infected compared to HIV-uninfected subjects with active tuberculosis.
    Waruk JL; Machuki Z; Mesa C; Juno JA; Anzala O; Sharma M; Ball TB; Oyugi J; Kiazyk S
    Tuberculosis (Edinb); 2015 Sep; 95(5):555-61. PubMed ID: 26073895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
    Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
    J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study.
    Shivakoti R; Gupte N; Tripathy S; Poongulali S; Kanyama C; Berendes S; Cardoso SW; Santos BR; La Rosa A; Mwelase N; Pillay S; Samaneka W; Riviere C; Sugandhavesa P; Bollinger RC; Balagopal A; Semba RD; Christian P; Campbell TB; Gupta A;
    BMC Med; 2018 Sep; 16(1):161. PubMed ID: 30244671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV.
    Farr K; Ravindran R; Strnad L; Chang E; Chaisson LH; Yoon C; Worodria W; Andama A; Ayakaka I; Bbosa Nalwanga P; Byanyima P; Kalema N; Kaswabuli S; Katagira W; Aman KD; Musisi E; Tumwine NW; Sanyu I; Ssebunya R; Davis JL; Huang L; Khan IH; Cattamanchi A
    PLoS One; 2018; 13(10):e0206119. PubMed ID: 30352099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
    Penn-Nicholson A; Hraha T; Thompson EG; Sterling D; Mbandi SK; Wall KM; Fisher M; Suliman S; Shankar S; Hanekom WA; Janjic N; Hatherill M; Kaufmann SHE; Sutherland J; Walzl G; De Groote MA; Ochsner U; Zak DE; Scriba TJ;
    PLoS Med; 2019 Apr; 16(4):e1002781. PubMed ID: 30990820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Tuberculosis in advanced HIV infection is associated with increased expression of IFNγ and its downstream targets".
    Verma S; Du P; Nakanjako D; Hermans S; Briggs J; Nakiyingi L; Ellner JJ; Manabe YC; Salgame P
    BMC Infect Dis; 2018 May; 18(1):220. PubMed ID: 29764370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of tests for latent tuberculosis in different groups of immunocompromised patients.
    Richeldi L; Losi M; D'Amico R; Luppi M; Ferrari A; Mussini C; Codeluppi M; Cocchi S; Prati F; Paci V; Meacci M; Meccugni B; Rumpianesi F; Roversi P; Cerri S; Luppi F; Ferrara G; Latorre I; Gerunda GE; Torelli G; Esposito R; Fabbri LM
    Chest; 2009 Jul; 136(1):198-204. PubMed ID: 19318676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of a new interferon-gamma release assay for the diagnosis of tuberculosis infection in HIV-infected individuals in China.
    Yu L; Mo P; Wei Z; Fu R; Yang M; Ji B; Wang J; Li S; Strong AJ; Touzjian N; Kushner N; Gui XE; Lu Y; Zhao Z
    Infect Dis (Lond); 2015 Apr; 47(4):237-43. PubMed ID: 25712792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
    You E; Kim MH; Lee WI; Kang SY
    Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.